Skip to content

Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care Unit

Can You Hear Me? Assessment of Verbal Comprehension and Cognitive Processes in Patients in the Last Days of Life

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05091632
Enrollment
30
Registered
2021-10-25
Start date
2021-05-04
Completion date
2027-02-02
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic and Lymphoid Cell Neoplasm, Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm

Brief summary

This study investigates the use electroencephalography (EEG - a test that measures brain waves) to learn if patients who appear unresponsive (do not respond to noises, words, or touch) retain any consciousness. Families want to know if their loved ones who are unresponsive can still hear them or feel any discomfort. Information gained from this study may have important impact in how patients, caregivers, and doctors make decisions.

Detailed description

PRIMARY OBJECTIVES: I. To estimate the magnitude of electroencephalography (EEG) response to verbal stimuli among cancer patients in the last days in life admitted to a palliative and supportive care unit (PSCU). II. To examine the feasibility of conducting EEG in cancer patients in the last days of life. SECONDARY OBJECTIVES: I. To compare the magnitude of EEG response between impending death cohort and control cohort. II. To determine the association between the magnitude of EEG response and clinical assessments (e.g. JFK Coma Recovery Scale-Revised \[CRS-R\], Glasgow Coma Scale \[GCS\], Richmond Agitation Sedation Scale \[RASS\], Memorial Delirium Assessment Scale \[MDAS\]) in impending death cohort and control cohort separately. III. To determine the magnitude of EEG response to pressure/noxious stimuli in impending death cohort and control cohort separately. IV. To examine serial EEG changes in auditory cortex activation and cognitive processing in cancer patients over the last days of life. OUTLINE: Patients undergo EEG over 30 minutes daily until death or discharge and complete questionnaires over 30 minutes daily until death or discharge to check level of consciousness, thought, and ability to communicate.

Interventions

PROCEDUREElectroencephalography

Undergo EEG

OTHERQuestionnaire Administration

Complete questionnaires

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. \[Both cohorts\] Diagnosis of advanced cancer (defined as locally advanced, metastatic, recurrent, or incurable disease) 2. \[Both cohorts\] Admitted to the PSCU at MD Anderson Cancer Center or seen by the specialist palliative care inpatient consultation team (control cohort only) 3. \[Impending death cohort\] Clinician judgement of .3 days of survival or .1 late sign of impending death\* 4. \[Impending death cohort\] Palliative Performance Scale score of 10-20% 5. \[Control cohort\] Able to communicate for the past 24 hours 6. \[Control cohort\] Clinician judgement of .1 month of survival 7. \[Both cohorts\] English-speaking

Exclusion criteria

1. \[Both cohorts\] Hearing impairment that significantly impacts daily communication with caregiver prior to entering impending death phase OR requiring hearing aid 2. \[Impending death cohort\] Mental status changes only related to medications as per clinician judgement 3. \[Control cohort\] Diagnosis of delirium (i.e. MDAS .13) 4. \[Both cohorts\] Pregnant women 5. \[Both Cohorts\] Age \< 18 years old

Design outcomes

Primary

MeasureTime frameDescription
Magnitude of electroencephalography (EEG) response to verbal stimuli among impending death cancer patientsDay 1 in palliative and supportive care unitThe magnitudes of EEG responses in each task will be calculated as the difference between pre-stimulus and post-stimulus, separately. 95% confidence intervals will be estimated for each task.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDavid Hui

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026